Full-spectrum vs broad-spectrum CBD: full UK 2026 guide

Full-spectrum CBD characteristics

Full-spectrum CBD contains all naturally occurring hemp cannabinoids + sustained UK regulatory compliance + UK 18+ verification at established UK retailers. Whole-plant cannabinoid profile: CBD (cannabidiol) primary + CBG (cannabigerol) + CBN (cannabinol) + CBC (cannabichromene) + minor cannabinoids + terpenes + flavonoids + naturally occurring up to 1mg THC max per container UK regulatory limit. Entourage effect concept: theoretical concept that hemp cannabinoids may work synergistically + scientific research ongoing + not validated medical claim + sustained UK consumer awareness. 1mg THC maximum per container: UK Misuse of Drugs Regulations + sustained UK regulatory compliance + non-psychoactive at this concentration + sustained UK consumer protection. Lab testing certificates verify content: established UK retailers (UK Companies House + VAT registered + UK Trading Standards monitored) provide third-party Certificate of Analysis (COA) + cannabinoid profile + sustained UK consumer transparency. UK Novel Food regulation: full-spectrum CBD edibles require FSA Novel Food authorisation since 31 March 2021 + sustained UK Trading Standards quality. Drug interactions caution: CBD can interact with medications metabolised by CYP3A4 + CYP2C19 enzymes; always consult GP if taking prescription medication. UK 18+ verification: established UK retailers verify age + never sold to under-18s + sustained UK consumer protection. FSA 70mg/day recommendation applies: cumulative across all CBD products regardless of spectrum + sustained UK consumer protection. UK FSA compliant. CBD is a food supplement not a medicine. For UK CBD legality see are CBD edibles legal UK.

Broad-spectrum CBD characteristics

Broad-spectrum CBD contains multiple cannabinoids and terpenes with THC removed during processing + sustained UK regulatory compliance + UK 18+ verification at established UK retailers. Multi-cannabinoid profile + THC removed: CBD (cannabidiol) primary + CBG + CBN + CBC + minor cannabinoids + terpenes + flavonoids retained; THC removed via additional processing step (chromatography or distillation). No THC content: 0mg THC typical broad-spectrum + sustained UK regulatory compliance + choice for THC-sensitive UK adult users. Choice for THC-sensitive users: those wishing to avoid any THC content for personal preference + workplace drug testing concerns + sustained UK consumer choice. Theoretical entourage effect retained partially: minus THC contribution + non-validated medical claim + scientific research ongoing. Lab testing certificates verify zero THC content: established UK retailers (UK Companies House + VAT registered + UK Trading Standards monitored) provide third-party Certificate of Analysis (COA) + sustained UK consumer transparency. UK Novel Food regulation: broad-spectrum CBD edibles require FSA Novel Food authorisation since 31 March 2021 + sustained UK Trading Standards quality. Drug interactions caution all spectrum types: CBD can interact with medications metabolised by CYP3A4 + CYP2C19 enzymes; always consult GP if taking prescription medication. UK 18+ verification: established UK retailers verify age + never sold to under-18s + sustained UK consumer protection. FSA 70mg/day recommendation applies: cumulative across all CBD products + sustained UK consumer protection. UK FSA compliant. CBD is a food supplement not a medicine. For dosing CBD see dose CBD edibles safely.

CBD isolate characteristics

CBD isolate contains pure CBD only + 99%+ purity + no other cannabinoids or terpenes + sustained UK regulatory compliance + UK 18+ verification at established UK retailers. 99%+ pure CBD profile: all other cannabinoids removed during processing + no CBG + no CBN + no CBC + no terpenes + no flavonoids + no THC + sustained UK consumer choice. Crystalline white powder typically: pure CBD form + can be incorporated into gummies + oils + other formats. No entourage effect: pure CBD only + no synergistic cannabinoid interaction + scientific research ongoing on entourage effect concept. Choice for users wanting only CBD: avoid all other cannabinoids + workplace drug testing certainty + sustained UK consumer choice. Predictable mg-by-mg dosing: pure CBD content allows precise dose calculation + sustained UK consumer awareness. Lab testing certificates verify 99%+ purity: established UK retailers (UK Companies House + VAT registered + UK Trading Standards monitored) provide third-party Certificate of Analysis (COA) + sustained UK consumer transparency. UK Novel Food regulation: CBD isolate edibles require FSA Novel Food authorisation since 31 March 2021 + sustained UK Trading Standards quality. Drug interactions caution: CBD interacts with medications metabolised by CYP3A4 + CYP2C19 enzymes regardless of spectrum; always consult GP if taking prescription medication. UK 18+ verification: established UK retailers verify age + never sold to under-18s + sustained UK consumer protection. FSA 70mg/day recommendation applies: cumulative across all CBD products + sustained UK consumer protection. UK FSA compliant. CBD is a food supplement not a medicine. For safe CBD limits see safe CBD limits.

Spectrum selection by user profile

Methodical CBD spectrum selection by user profile + matched preferences + sustained UK adult use + sustained UK retailer relationships. Choose full-spectrum if: theoretical entourage effect interest + comfortable with up to 1mg THC max per container + whole-plant cannabinoid profile preference; sustained UK adult choice. Choose broad-spectrum if: theoretical entourage effect partial + want to avoid all THC + multi-cannabinoid profile preference; sustained UK adult choice. Choose CBD isolate if: only CBD desired + want to avoid all other cannabinoids + workplace drug testing certainty + predictable single-cannabinoid dosing; sustained UK adult choice. UK workplace drug testing considerations: workplace drug testing typically tests for THC; full-spectrum may produce trace THC results in sensitive testing; broad-spectrum + isolate provide certainty; sustained UK consumer awareness; consult employer policy. FSA 70mg/day recommendation all spectrum types: cumulative across all CBD products regardless of spectrum + sustained UK consumer protection. Drug interactions all spectrum types: CBD interacts with CYP3A4 + CYP2C19 medications regardless of spectrum; always consult GP if taking prescription medication. Pregnancy + breastfeeding all spectrum types: FSA precautionary advice + insufficient evidence + sustained UK consumer protection. Underlying health conditions all: GP consultation essential + sustained UK consumer protection. Methodical consumption practice all: start low + monitor response 1-2 weeks + adjust gradually + sustained UK consumer protection. UK 18+ verification all: established UK retailers verify age + never sold to under-18s. UK consumer rights all: faulty products = retailer replacement obligation under Consumer Rights Act 2015. UK FSA compliant. For dosing CBD see dose CBD edibles safely.

UK Novel Food regulation all spectrum types

All CBD spectrum types require UK Novel Food authorisation + sustained UK regulatory compliance + UK Trading Standards quality + sustained UK consumer protection. FSA Novel Food authorisation required since 31 March 2021: applies to all spectrum types (full + broad + isolate) + ongoing FSA review process + sustained UK Trading Standards quality. FSA public list of products: maintained for all spectrum types + sustained UK consumer transparency + verification. 1mg THC maximum per container all formats: UK Misuse of Drugs Regulations + sustained UK regulatory compliance; full-spectrum may contain up to this limit + broad-spectrum + isolate contain zero THC typical. Lab testing certificates all spectrum types: established UK retailers provide third-party Certificate of Analysis (COA) + cannabinoid profile + THC content + heavy metal screening + pesticide screening; sustained UK consumer transparency + UK Trading Standards quality. Counterfeit prevention all spectrum types: counterfeit signs significantly cheaper than typical pricing + missing Novel Food application listing + missing lab testing certificates + suspicious supply chain + missing FSA-compliant labelling. Established UK retailers (UK Companies House + VAT registered + UK Trading Standards monitored): ensure UK Novel Food authorised products all spectrum types + counterfeit prevention + UK 18+ age verification + sustained UK consumer protection + sustained UK retailer relationships. UK Trading Standards investigations: counterfeit + non-compliant CBD products + sustained UK consumer protection. Labelling requirements all spectrum types: CBD content per serving + total CBD content per container + spectrum type + ingredients + nutritional information + storage instructions + best-before date + manufacturer details + warnings (suitable for adults only + don't exceed FSA 70mg/day recommendation). UK 18+ verification all: established UK retailers verify age + never sold to under-18s + sustained UK consumer protection. UK consumer rights all: faulty products = retailer replacement obligation under Consumer Rights Act 2015. NHS guidance all spectrum types: CBD products are not medicines + cannot diagnose + treat + cure + prevent any condition + always consult GP if taking medication or pregnant or breastfeeding or underlying conditions + sustained UK consumer protection. UK FSA compliant. For safe CBD limits see safe CBD limits.

Choose your CBD spectrum type + full + broad + isolate + matched user profile + UK Novel Food regulated + 1mg THC max + UK 18+ verification + within FSA 70mg/day recommendation. Always consult GP if taking medication or pregnant or breastfeeding. CBD is a food supplement not a medicine. To pick up your CBD edibles see the CBD edibles collection.